6 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... thrombosis. ... DVT = deep vein ... #Algorithm #Anticoagulation ... #Management #Hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
and incidental DVT ... or PE in cancer ... catheter-related thrombosis ... #Algorithm #Anticoagulation ... #Management #Hematology
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
/Muscular Vein Thrombosis ... Thrombophilia • Cancer ... Bloodman #VTE #anticoagulation ... #duration #management ... #length #treatment
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
may precede the neurologic ... Autoimmune disease, Cancer ... Cerebral venous thrombosis ... epilepticus Treatment ... #management #neurology
Behçet's Syndrome
Systemic disease associated with inflammation of multiple organs, small-vessel vasculitis and large-vessel vasculopathy
Epidemiology:
 • Young
skin injury) • Neurologic ... Venous disease (SVC ... syndrome, dural sinus thrombosis ... Arthritis, AS Treatment ... #management #signs
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
MI, stroke, DVT/ ... Splenomegaly Diagnosis ... A conclusive diagnosis ... Hydroxyurea + anticoagulation ... #management #hematology